Akognos Life Sciences Private Limited, a active private limited company, was established on 22 December 2015 in Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999DL2015PTC288792. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 27 professional, Its leadership includes Seema Kaul (Director), Prashant Pareek (Director). Past directors included Seema Kaul, Rishi Mohan Srivastava, Nitish Dhingra. It holds ₹2.50 Cr open charges and ₹1.45 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Room No. 1 49, Chruch Road, Jangpura, Bhogal, Delhi, Delhi, 110014.
U74999DL2015PTC288792
288792
22 December 2015
₹1.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Akognos Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seema Kaul | Director | 02 Aug 2023 | Current |
| Prashant Pareek | Director | 10 Aug 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2016 | Past |
| Pramod Abcsdd | Additional Director | 13 May 2017 | Past |
| Pramod Abcsdd | Director | 01 Apr 2022 | Past |
| Pramod Abcsdd | Director | 01 Apr 2022 | Past |
| Pramod Abcsdd | Additional Director | 01 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Akognos Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.01% increase. The company also saw a substantial improvement in profitability, with a 207.55% increase in profit. The company's net worth Soared by an impressive increase of 75.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Akognos Life Sciences had a public holding of 0.13%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹25,000,000.00
₹1,450,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Dec 2017 | Indian Bank | ₹2.50 Cr | Open |
| 26 May 2017 | Others | ₹1.45 M | Satisfied |
Explore comprehensive loan charge details -
Akognos Life Sciences has a workforce of 27 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Akognos Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akognos Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Akognos Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Akognos Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.
Progress on A charge with Indian Bank of Rs. 2.50 Cr registered on 01 Dec 2017 with Charge ID 100144362 was modified on 21 Feb 2025. was documented.
The activity Seema Kaul was appointed as a Director was appointed as a Director on 02 Aug 2023 & has been associated with this company since 2 years 4 months . was completed.
The activity A charge registered on 26 May 2017 via Charge ID 100103850 with Others was fully satisfied on 01 Jan 2018. was completed.
A charge with Indian Bank amounted to Rs. 2.50 Cr with Charge ID 100144362 was registered on 01 Dec 2017. was recorded as a recent event.
The CIN of Akognos Life Sciences Private Limited is U74999DL2015PTC288792.
Akognos Life Sciences Private Limited is headquartered at Room No. 1 49, Chruch Road, Jangpura, Bhogal, Delhi, Delhi, 110014.
Akognos Life Sciences Private Limited was incorporated on 22 December 2015.
The current directors of Akognos Life Sciences Private Limited are
The primary industry of Akognos Life Sciences Private Limited is Trade.
Akognos Life Sciences Private Limited is unlisted.
The authorized capital of Akognos Life Sciences Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Akognos Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX